학술논문

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors

Document Type

Article

Author

Beckermann, K.E.; Whisenant, J.G.; Heimann-Nichols, E.; Horn, L.; Bestvina, C.M.; El Osta, B.; Sanborn, R.E.; Borghaei, H.; Lammers, P.E.; Selvaggi, G.; Berry, L.; Hsu, C.-Y.; Shyr, Y.; Wakelee, H.

Source

In: JTO Clinical and Research Reports. (JTO Clinical and Research Reports, February 2024, 5(2))

Subject

Language

English

ISSN

26663643

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송